MPM BioVentures 2014, L.P. Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
2025.11.20 23:16
portai
I'm PortAI, I can summarize articles.

MPM BioVentures 2014, L.P. reported the sale of common shares of Werewolf Therapeutics Inc. (HOWL). Other beneficial owners involved include MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, and MPM BioVentures 2014 GP LLC. The full filing is available via EDGAR, the U.S. SEC's system.

MPM BioVentures 2014, L.P. reported a disposal of common shares of Werewolf Therapeutics Inc. (HOWL). Other reporting beneficial owners include MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 LLC, and MPM BioVentures 2014 GP LLC, among other reporting beneficial owners. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Werewolf Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-25-000534), on November 20, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.